MHRA Drug Safety Update for April 2022
MHRA Drug Safety Update April 2022
Posted: Wednesday, April 20, 2022
Category - Medicines Update
Medicines Update
GGC Medicines Update is a series of blogs with important medicines related messages relevant to all healthcare professionals across GGC.
- Subscribe to our blog via email:ggc.medicines.update@nhs.scot
- Follow us on Twitter
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact ggc.medicines.update@nhs.scot.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC responsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for further information and here for a guide to blog writing. When you email the committee to discuss writing a blog, you will be sent a checklist to complete prior to submitting the blog for review.
Safe Use of Lithium
Posted: Friday, April 15, 2022
Category - Medicines Update
Key messages: Lithium is a gold standard treatment for maintenance treatment of bipolar affective disorder Lithium has a high potential for toxicity and requires careful monitoring to ensure its safe and...
Guideline News March 2022
Posted: Monday, April 11, 2022
Category - Medicines Update
MHRA Drug Safety Update March 2022
Posted: Friday, April 1, 2022
Category - Medicines Update
MHRA Drug Safety Update for March 2022
Key Medicine Shortages – April 2022
Posted: Friday, April 1, 2022
Category - Medicines Update
Key Medicine Shortages for April 2022
Guideline News February 2022
Posted: Thursday, March 10, 2022
Category - Medicines Update
MHRA Drug Safety Update February 2022
Posted: Tuesday, March 8, 2022
Category - Medicines Update
MHRA Drug Safety Update for February 2022
Penicillin Allergy
Posted: Monday, February 28, 2022
Category - Medicines Update
Key Medicine Shortages – March 2022
Posted: Monday, February 28, 2022
Category - Medicines Update
Key Medicine Shortages for March 2022
New Shared Care Agreement: Methotrexate for Dermatology Indications
Posted: Wednesday, February 23, 2022
Category - Medicines Update
A new Shared Care Agreement (SCA) for subcutaneous methotrexate has been approved for use in adult patients with psoriasis or eczema and other inflammatory skin conditions.